Michael Forte

Michael Forte is an experienced executive in business development within the clinical research industry. Currently serving as the Executive Director of Business Development for Early Phase at Worldwide Clinical Trials since January 2024, Michael oversees early phase clinical studies. Previously, Michael held the position of Vice President of Business Development for North America at Veristat from November 2022 to December 2023, managing business development for CRO and biometrics and regulatory services. Michael has extensive consulting experience from April 2009 to October 2022, providing business development, marketing, and clinical development services to various organizations including the Harvard Clinical Research Institute. In addition, Michael served as Vice President of Sales and Marketing at Clinlogix until its acquisition by NAMSA in December 2021 and as Executive Director at KCR, SA from March 2017 to March 2020, focusing on commercial development and clinical trial execution solutions. Michael's educational background includes studies at Drexel University College of Medicine and East Carolina University.